The Hippurate Ratio as an Indicator of Functional Hepatic Reserve for Resection of Hepatocellular Carcinoma in Cirrhotic Patients

Journal of Gastrointestinal Surgery

Volumn 5, Issue 3, 2001, Pages 316-321

  Hemming, Alan W ^a,e   Gallinger, Steven ^b   Greig, Paul D ^b   Cattral, Mark S ^b   Langer, Bernard ^b   Taylor, Bryce R ^b   Verjee, Zulfikarali ^c   Giesbrecht, Esther ^c   Nakamachi, Yoshiko ^c   Furuya, Katryn N ^c,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Indocyanine green; Liver function; Liver resection; Paraminobenzoic acid

Indexed keywords

4 ACETYLAMINOHIPPURIC ACID; 4 AMINOBENZOIC ACID; 4 AMINOHIPPURIC ACID; 4-ACETYLAMINOHIPPURIC ACID; COLORING AGENT; DIAGNOSTIC AGENT; GLYCINE; HIPPURIC ACID DERIVATIVE; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HOSPITALIZATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; LIVER RESECTION; LIVER TUMOR; MALE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; PREOPERATIVE CARE; PROSPECTIVE STUDY; STANDARD; VALIDATION STUDY;

4-AMINOBENZOIC ACID; ADULT; AGED; AMINOHIPPURIC ACIDS; CARCINOMA, HEPATOCELLULAR; COLORING AGENTS; FEMALE; GLYCINE; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; P-AMINOHIPPURIC ACID; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 18044404292     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)80054-8     Document Type: Article

References (31)

1. Loetze MFJ, Carr B. Hepatobiliary neoplasms. In Devita VT, ed. Cancer: Principles and Practice of Oncology. Philadelphia: JB Lippincott, 1993, pp 883-914.
2. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Rigamonti A, Barbara C, Grigioni W, Mazziotti A, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132-137.
3. Hemming AW, Greig PD, Langer B. Current surgical management of primary hepatocellular carcinoma. Adv Surg 1999;32:169-192.
4. Bradley AL, Chapman WC, Wright JK, Marsh JW, Geevarghese S, Blair KT, Pinson CW. Surgical experience with hepatic colorectal metastasis. Am Surg 1999;65:560-566; discussion 566-567.
5. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, Plaud B, Ducreux M, Spielmann M, Theodore C, Bonvalot S, Lasser P. Resection of liver metastases from a noncolorectal primary: Indications and results based on 147 monocentric patients. J Am Coll Surg 1998;187:487-493.
6. Fong Y, Former J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309-318; discussion 318-321.
7. Hemming AW, Sielaff TD, Gallinger S, Cattral MS, Taylor BR, Greig PD, Langer B. Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl 2000;6:97-101.
8. Philosophe B, Greig PD, Hemming AW, Cattral MS, Wanless I, Rasul I, Baxter N, Taylor BR, Langer B. Surgical management of hepatocellular carcinoma: Resection or transplantation? J GASTROINTEST SURG 1998;2:21-27.
9. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218: 145-151.
10. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790-799; discussion 799-800.
11. Lau H, Fan ST, Ng IO, Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: A survival analysis of 204 consecutive patients. Cancer 1998;83:2302-2311.
12. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992;163:515-518.
13. Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Yanaga K, Sugimachi K. Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 1998;85:195-198.
14. Koren G, Weizman Z, Forstner G, MacLeod SM, Durie PR. Altered PABA pharmacokinetics in cystic fibrosis. Implications for bentiromide test. Dig Dis Sci 1985;30:928-932.
15. Laufer D, Cleghorn G, Forstner G, Ellis L, Koren G, Durie P. The bentiromide test using plasma p-aminobenzoic acid for diagnosing pancreatic insufficiency in young children. The effect of two different doses and a liquid meal. Gastroenterology 1991;101:207-213.
16. Kubota K. Ultrasonography: Intraoperative. In Livraghi T, Buscarini L, eds. Diagnosis and Treatment of Hepatocellular Carcinoma. London: Greenwich Medical Media, 1997, p 114.
17. Yung-Jato LL, Durie PR, Soldin SJ. Liquid-chromatographic measurement of p-aminobenzoic acid and its metabolites in serum. Clin Chem 1988;34:2235-2238.
18. Nagasue N, Kohno H, Tachibana M, Yamanoi A, Ohmori H, El-Assal ON. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann Surg 1999;229:84-90.
19. Paquet KJ, Gad HA, Lazar A, Koussouris P, Mercado MA, Heine WD, Jachman-Jahn V, Ruppert W. Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma. Eur J Surg 1998; 164:513-519.
20. Kubo S, Nishiguchi S, Shuto T, Tanaka H, Tsukamoto T, Hirohashi K, Ikebe T, Wakasa K, Kuroki T, Kinoshita H. Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma. Jpn J Cancer Res 1999;90:162-170.
21. Fong Y, Salo J. Surgical therapy of hepatic colorectal metastasis. Semin Oncol 1999;26:514-523.
22. Bismuth H, Chiche L. Comparison of hepatic resection and transplantation in the treatment of liver cancer. Semin Surg Oncol 1993;9:341-345.
23. Ercolani G, Grazi GL, Calliva R, Pierangeli F, Cescon M, Cavallari A, Mazziotti A. The lidocaine (MEGX) test as an index of hepatic function: Its clinical usefulness in liver surgery. Surgery 2000;127:464-471.
24. Zoedler T, Ebener C, Becker H, Roeher HD. Evaluation of liver function tests to predict operative risk in liver surgery. HPB Surg 1995;9:13-18.
25. Mori K, Ozawa K, Yamamoto Y, Maki A, Shimahara Y, Kobayashi N, Yamaoka Y, Kumada K. Response of hepatic mitochondrial redox state to oral glucose load. Redox tolerance test as a new predictor of surgical risk in hepatectomy. Ann Surg 1990;211:438-446.
26. Ueda J, Mori K, Sakai Y, Tanaka A, Katayama T, Maki A, Shimahara Y, Yamaoka Y, Ozawa K. Noninvasive evaluation of cytochrome c oxidase activity of the liver. Its prognostic value for hepatic resection. Arch Surg 1994;129:303-308.
27. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997; 84:1255-1259.
28. Krahenbuhl L, Reichen J, Talos C, Krahenbuhl S. Benzoic acid metabolism reflects hepatic mitochondrial function in rats with long-term extrahepatic cholestasis. Hepatology 1997;25: 278-283.
29. Gregus Z, Fekete T, Halaszi E, Klaassen CD. Does hepatic ATP depletion impair glycine conjugation in vivo? Drug Metab Dispos 1996;24:1347-1354.
30. Furuya KN, Durie PR, Roberts EA, Soldin SJ, Verjee Z, Yung-Jato L, Giesbrecht E, Ellis L. Glycine conjugation of para-aminobenzoic acid (PABA): A quantitative test of liver function. Clin Biochem 1995;28:531-540.
31. Nonami T, Nakao A, Kurokawa T, Inagaki H, Matsushita Y, Sakamoto J, Takagi H. Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 1999;46:1669-1672.